Galmed Pharmaceuticals
GLMD
#10243
Rank
NZ$6.13 M
Marketcap
$2.71
Share price
-0.61%
Change (1 day)
-66.43%
Change (1 year)

Earnings for Galmed Pharmaceuticals (GLMD)

Earnings in 2024 (TTM): -NZ$10.18 Million

According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$11.59 Million, an increase over its 2022 earnings that were of -NZ$29.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galmed Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$10.18 Million-12.15%
2023 -NZ$11.59 Million-61.31%
2022 -NZ$29.94 Million-44.97%
2021 -NZ$54.41 Million12.85%
2020 -NZ$48.22 Million40.61%
2019 -NZ$34.29 Million109.19%
2018 -NZ$16.4 Million-20.47%
2017 -NZ$20.62 Million-27%
2016 -NZ$28.24 Million58.6%
2015 -NZ$17.81 Million16.7%
2014 -NZ$15.26 Million-47.94%
2013 -NZ$29.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.16 Billion 1,338.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$4.01 Billion 37,722.90%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-NZ$38.95 Million 267.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$8.13 Million-23.30%๐Ÿ‡บ๐Ÿ‡ธ USA